Mr. Vito Sanzone reports

PROMINO NUTRITIONAL SCIENCES INC. COMMENTS ON TRADING HALT

Promino Nutritional Sciences Inc. has provided an update on the trading halt issued by the Canadian Investment Regulatory Organization and the cease trade order from the Ontario Securities Commission on Thursday, May 8, 2025, as a result of the company's delay in filing its audited financial statements for the year ended Dec. 31, 2024.

The delay is primarily caused by extended audit timelines resulting from the company's acquisition of Helios Helium Corp. on Aug. 2, 2024. The acquisition of Helios provided the company with $2-million in cash and $1-million in securities, a significant injection of capital.

Promino chief executive officer Vito Sanzone commented: "The trading halt and cease trade order are unfortunate but temporary administrative consequences of the restructuring and recapitalization work we undertook in 2024. For a small company like Promino, these transactions add significant accounting and legal complexity, and our audit team required additional time to verify the documentation. We aim to complete our audit and resume trading promptly."

About Promino Nutritional Sciences Inc.

Promino is an innovative and research-driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle Activator, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. The company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ont.

We seek Safe Harbor.